Spain · Delayed Price · Currency is EUR Metrovacesa Statistics
Total Valuation
Metrovacesa has a market cap or net worth of EUR 1.69 billion. The enterprise value is 1.92 billion.
| Market Cap | 1.69B |
| Enterprise Value | 1.92B |
Important Dates
The last earnings date was Wednesday, July 22, 2026.
| Earnings Date | Jul 22, 2026 |
| Ex-Dividend Date | May 20, 2026 |
Share Statistics
Metrovacesa has 151.65 million shares outstanding. The number of shares has increased by 0.02% in one year.
| Current Share Class | 151.65M |
| Shares Outstanding | 151.65M |
| Shares Change (YoY) | +0.02% |
| Shares Change (QoQ) | +0.03% |
| Owned by Insiders (%) | 0.10% |
| Owned by Institutions (%) | 2.58% |
| Float | 6.83M |
Valuation Ratios
The trailing PE ratio is 18.69 and the forward PE ratio is 25.13.
| Price/FFO Ratio | n/a |
| Price/AFFO Ratio | n/a |
| PE Ratio | 18.69 |
| Forward PE | 25.13 |
| PS Ratio | 1.89 |
| PB Ratio | 1.30 |
| P/TBV Ratio | 1.30 |
| P/FCF Ratio | 3.92 |
| P/OCF Ratio | 3.92 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.84, with an EV/FCF ratio of 4.45.
| EV / Earnings | 21.24 |
| EV / Sales | 2.14 |
| EV / EBITDA | 14.84 |
| EV / EBIT | 14.84 |
| EV / FCF | 4.45 |
Financial Position
The company has a current ratio of 3.28, with a Debt / Equity ratio of 0.30.
| Current Ratio | 3.28 |
| Quick Ratio | 0.47 |
| Debt / Equity | 0.30 |
| Debt / EBITDA | 3.02 |
| Debt / FCF | 0.91 |
| Interest Coverage | 4.75 |
Financial Efficiency
Return on equity (ROE) is 6.42% and return on invested capital (ROIC) is 7.77%.
| Return on Equity (ROE) | 6.42% |
| Return on Assets (ROA) | 4.55% |
| Return on Invested Capital (ROIC) | 7.77% |
| Return on Capital Employed (ROCE) | 8.07% |
| Weighted Average Cost of Capital (WACC) | 7.54% |
| Revenue Per Employee | 4.25M |
| Profits Per Employee | 429,452 |
| Employee Count | 210 |
| Asset Turnover | 0.39 |
| Inventory Turnover | 0.41 |
Taxes
In the past 12 months, Metrovacesa has paid 23.75 million in taxes.
| Income Tax | 23.75M |
| Effective Tax Rate | 20.85% |
Stock Price Statistics
The stock price has increased by +9.56% in the last 52 weeks. The beta is 0.68, so Metrovacesa's price volatility has been lower than the market average.
| Beta (5Y) | 0.68 |
| 52-Week Price Change | +9.56% |
| 50-Day Moving Average | 10.93 |
| 200-Day Moving Average | 11.03 |
| Relative Strength Index (RSI) | 51.35 |
| Average Volume (20 Days) | 108,458 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Metrovacesa had revenue of EUR 893.22 million and earned 90.19 million in profits. Earnings per share was 0.59.
| Revenue | 893.22M |
| Gross Profit | 220.17M |
| Operating Income | 165.51M |
| Pretax Income | 113.94M |
| Net Income | 90.19M |
| EBITDA | 129.12M |
| EBIT | 129.12M |
| Earnings Per Share (EPS) | 0.59 |
Balance Sheet
The company has 159.82 million in cash and 389.35 million in debt, with a net cash position of -229.53 million or -1.51 per share.
| Cash & Cash Equivalents | 159.82M |
| Total Debt | 389.35M |
| Net Cash | -229.53M |
| Net Cash Per Share | -1.51 |
| Equity (Book Value) | 1.30B |
| Book Value Per Share | 8.55 |
| Working Capital | 1.21B |
Cash Flow
In the last 12 months, operating cash flow was 430.08 million and capital expenditures 32,000, giving a free cash flow of 430.11 million.
| Operating Cash Flow | 430.08M |
| Capital Expenditures | 32,000 |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | 430.11M |
| FCF Per Share | 2.84 |
Margins
Gross margin is 24.65%, with operating and profit margins of 18.53% and 10.10%.
| Gross Margin | 24.65% |
| Operating Margin | 18.53% |
| Pretax Margin | 12.76% |
| Profit Margin | 10.10% |
| EBITDA Margin | 22.45% |
| EBIT Margin | 22.45% |
| FCF Margin | 48.15% |
Dividends & Yields
This stock pays an annual dividend of 2.02, which amounts to a dividend yield of 18.17%.
| Dividend Per Share | 2.02 |
| Dividend Yield | 18.17% |
| Dividend Growth (YoY) | 155.70% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 339.55% |
| Buyback Yield | -0.02% |
| Shareholder Yield | 18.14% |
| Earnings Yield | 5.35% |
| FCF Yield | 25.51% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for Metrovacesa is 10.73, which is -1.74% lower than the current price. The consensus rating is "Sell".
| Price Target | 10.73 |
| Price Target Difference | -1.74% |
| Analyst Consensus | Sell |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 2.31% |
| EPS Growth Forecast (3Y) | -8.42% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |